Galena Biopharma Inc. (GALE)

5.72
0.00 (0.00)
NASDAQ : Health Technology
Prev Close 5.72
Open 5.72
Day Low/High 5.56 / 5.85
52 Wk Low/High 3.43 / 19.80
Volume 55.42K
Avg Volume 886.60K
Exchange NASDAQ
Shares Outstanding 45.71M
Market Cap 11.98M
EPS -2,128.20
P/E Ratio N/A
Div & Yield N.A. (N.A)
Galena, Free Fentanyl Samples and the 'Zombie Apocalypse'

Galena, Free Fentanyl Samples and the 'Zombie Apocalypse'

Fund manager and blogger John Hempton calls out Galena Biopharma for giving away free samples of the potentially deadly fentanyl painkiller Abstral.

Biotech Stock Mailbag: Cell Therapeutics and the Ariad Hostile React-o-Meter Meltdown

Biotech Stock Mailbag: Cell Therapeutics and the Ariad Hostile React-o-Meter Meltdown

Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

Galena Biopharma (GALE) Is Today's Perilous Reversal Stock

Galena Biopharma (GALE) Is Today's Perilous Reversal Stock

Trade-Ideas LLC identified Galena Biopharma (GALE) as a "perilous reversal" (up big yesterday but down big today) candidate

Trade-Ideas: Galena Biopharma (GALE) Is Today's "Dead Cat Bounce" Stock

Trade-Ideas: Galena Biopharma (GALE) Is Today's "Dead Cat Bounce" Stock

Trade-Ideas LLC identified Galena Biopharma (GALE) as a "dead cat bounce" (down big yesterday but up big today) candidate

3 Oncology Biotechs to Watch

3 Oncology Biotechs to Watch

Handicapping the potential of Galena Biopharma, CytRx and Northwest Biotherapeutics requires a solid understanding of what has been driving share prices.

First Week of GALE March 22nd Options Trading

First Week of GALE March 22nd Options Trading

Investors in Galena Biopharma Inc saw new options begin trading this week, for the March 22nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GALE options chain for the new March 22nd contracts and identified one put and one call contract of particular interest.

Galena Biopharma (GALE) Drops Despite Analyst Upgrades

Galena Biopharma (GALE) Drops Despite Analyst Upgrades

Galena Biopharma (GALE) drops Tuesday despite two analyst upgrades.

Water-Logged And Getting Wetter: Galena Biopharma (GALE)

Water-Logged And Getting Wetter: Galena Biopharma (GALE)

Trade-Ideas LLC identified Galena Biopharma (GALE) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate

Jim Cramer's 'Mad Money' Recap: Buying Retail (Correct)

Jim Cramer's 'Mad Money' Recap: Buying Retail (Correct)

Questions on the continued strength of the consumer will be answered when Amazon reports, Cramer says.

Galena Is Stirring Traders' Passions

This biotech comes with high hopes and question marks.

Today's Perilous Reversal Stock: Galena Biopharma (GALE)

Today's Perilous Reversal Stock: Galena Biopharma (GALE)

Trade-Ideas LLC identified Galena Biopharma (GALE) as a "perilous reversal" (up big yesterday but down big today) candidate

Jim Cramer's Top Stock Picks: AMZN LOCK GALE BAC

Jim Cramer's Top Stock Picks: AMZN LOCK GALE BAC

Cramer still loves Bank of America but advises you do your homework on Galena Biopharma.

Trade-Ideas: Galena Biopharma (GALE) Is Today's Post-Market Leader Stock

Trade-Ideas: Galena Biopharma (GALE) Is Today's Post-Market Leader Stock

Trade-Ideas LLC identified Galena Biopharma (GALE) as a post-market leader candidate

Galena Biopharma Inc (GALE): Today's Featured Health Care Laggard

Galena Biopharma Inc (GALE): Today's Featured Health Care Laggard

Galena Biopharma was a leading decliner within the health care sector, falling $0.28 (-3.9%) to $6.96 on heavy volume

The J.P. Morgan Healthcare Confab Monday Morning News Dump

The J.P. Morgan Healthcare Confab Monday Morning News Dump

It's still pre-dawn in San Francisco, a few hours from the start of the J.P. Morgan Healthcare Conference, but that hasn't stopped biotech and drug companies from dumping a ton of news and announcements into the market. Here's a brief look at what's making headlines this morning:

'Mad Money' Lightning Round: Intel Is Doing Everything Right

'Mad Money' Lightning Round: Intel Is Doing Everything Right

Cramer prefers Palo Alto Networks to Barracuda Networks and blesses Galena Biopharma.

Jim Cramer's 'Mad Money' Recap: What Could Go Wrong

Jim Cramer's 'Mad Money' Recap: What Could Go Wrong

Washington, China and oil prices are among the things keeping Cramer up at night.

Stock To Watch: Galena Biopharma (GALE) In Perilous Reversal

Stock To Watch: Galena Biopharma (GALE) In Perilous Reversal

Trade-Ideas LLC identified Galena Biopharma (GALE) as a "perilous reversal" (up big yesterday but down big today) candidate

Trade-Ideas: Galena Biopharma (GALE) Is Today's "Perilous Reversal" Stock

Trade-Ideas: Galena Biopharma (GALE) Is Today's "Perilous Reversal" Stock

Trade-Ideas LLC identified Galena Biopharma (GALE) as a "perilous reversal" (up big yesterday but down big today) candidate

Today's Dead Cat Bounce Stock: Galena Biopharma (GALE)

Today's Dead Cat Bounce Stock: Galena Biopharma (GALE)

Trade-Ideas LLC identified Galena Biopharma (GALE) as a "dead cat bounce" (down big yesterday but up big today) candidate

Perilous Reversal Stock: Galena Biopharma (GALE)

Perilous Reversal Stock: Galena Biopharma (GALE)

Trade-Ideas LLC identified Galena Biopharma (GALE) as a "perilous reversal" (up big yesterday but down big today) candidate

Biotech Stocks Partying Like It's 1999

Biotech Stocks Partying Like It's 1999

After a weak October, biotech stocks have rebounded in a big way in November. The sector is on pace for an history year of absolute and relative performance.

Biotech Stocks With Promise

Allocate to numerous attractive, but speculative positions.

Interesting GALE Put And Call Options For July 2014

Interesting GALE Put And Call Options For July 2014

Investors in Galena Biopharma Inc saw new options become available this week, for the July 2014 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 234 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Trade-Ideas: Galena Biopharma (GALE) Is Today's "Dead Cat Bounce" Stock

Trade-Ideas: Galena Biopharma (GALE) Is Today's "Dead Cat Bounce" Stock

Trade-Ideas LLC identified Galena Biopharma (GALE) as a "dead cat bounce" (down big yesterday but up big today) candidate